Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Primary amines and derivitves thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto

Primary amines and derivitves thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto

US Patent 9987252 · Granted Jun 5, 2018

Estimated economic value: $40,342,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Modulators of the prostacyclin (PGI2) receptor useful for the treatment of disor2025
Modulators of the prostacyclin (PGI2) receptor useful for the treatment of disor2025
Cannabinoid receptor modulators2024
Substituted tetrazolo[1,5-a]pyrazines and tetrazolo[1,5-c]pyrimidines as adenosi2024
Modulators of the beta-3 adrenergic receptor useful for the treatment or prevent2024
Somatostatin modulators and uses thereof2023
Cannabinoid receptor modulators2023
Cannabinoid receptor modulators2023
Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof2023
Crystalline forms and processes for the preparation of cannabinoid receptor modu2023
Modulators of the beta-3 adrenergic receptor useful for the treatment or prevent2023
Somatostatin modulators and uses thereof2022